279 related articles for article (PubMed ID: 15044631)
1. Characterization of novel L-threo-beta-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters.
Shimamoto K; Sakai R; Takaoka K; Yumoto N; Nakajima T; Amara SG; Shigeri Y
Mol Pharmacol; 2004 Apr; 65(4):1008-15. PubMed ID: 15044631
[TBL] [Abstract][Full Text] [Related]
2. DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters.
Shimamoto K; Lebrun B; Yasuda-Kamatani Y; Sakaitani M; Shigeri Y; Yumoto N; Nakajima T
Mol Pharmacol; 1998 Feb; 53(2):195-201. PubMed ID: 9463476
[TBL] [Abstract][Full Text] [Related]
3. Effects of threo-beta-hydroxyaspartate derivatives on excitatory amino acid transporters (EAAT4 and EAAT5).
Shigeri Y; Shimamoto K; Yasuda-Kamatani Y; Seal RP; Yumoto N; Nakajima T; Amara SG
J Neurochem; 2001 Oct; 79(2):297-302. PubMed ID: 11677257
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the tritium-labeled analog of L-threo-beta-benzyloxyaspartate binding to glutamate transporters.
Shimamoto K; Otsubo Y; Shigeri Y; Yasuda-Kamatani Y; Satoh M; Kaneko S; Nakagawa T
Mol Pharmacol; 2007 Jan; 71(1):294-302. PubMed ID: 17047096
[TBL] [Abstract][Full Text] [Related]
5. The substituted aspartate analogue L-beta-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3.
Esslinger CS; Agarwal S; Gerdes J; Wilson PA; Davis ES; Awes AN; O'Brien E; Mavencamp T; Koch HP; Poulsen DJ; Rhoderick JF; Chamberlin AR; Kavanaugh MP; Bridges RJ
Neuropharmacology; 2005 Nov; 49(6):850-61. PubMed ID: 16183084
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of (2S, 3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate (TFB-TBOA) on the astrocytic sodium responses to glutamate.
Bozzo L; Chatton JY
Brain Res; 2010 Feb; 1316():27-34. PubMed ID: 20026319
[TBL] [Abstract][Full Text] [Related]
7. Effects of a novel glutamate transporter blocker, (2S, 3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate (TFB-TBOA), on activities of hippocampal neurons.
Tsukada S; Iino M; Takayasu Y; Shimamoto K; Ozawa S
Neuropharmacology; 2005 Mar; 48(4):479-91. PubMed ID: 15755476
[TBL] [Abstract][Full Text] [Related]
8. Concise Asymmetric Synthesis and Pharmacological Characterization of All Stereoisomers of Glutamate Transporter Inhibitor TFB-TBOA and Synthesis of EAAT Photoaffinity Probes.
Leuenberger M; Ritler A; Simonin A; Hediger MA; Lochner M
ACS Chem Neurosci; 2016 May; 7(5):534-9. PubMed ID: 26918289
[TBL] [Abstract][Full Text] [Related]
9. The glutamate transporters EAAT2 and EAAT3 mediate cysteine uptake in cortical neuron cultures.
Chen Y; Swanson RA
J Neurochem; 2003 Mar; 84(6):1332-9. PubMed ID: 12614333
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of threo-3-methylglutamic acid with excitatory amino acid transporters in native and recombinant systems.
Eliasof S; McIlvain HB; Petroski RE; Foster AC; Dunlop J
J Neurochem; 2001 Apr; 77(2):550-7. PubMed ID: 11299317
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of carbamate-type caged derivatives of a novel glutamate transporter blocker.
Takaoka K; Tatsu Y; Yumoto N; Nakajima T; Shimamoto K
Bioorg Med Chem; 2004 Jul; 12(13):3687-94. PubMed ID: 15186854
[TBL] [Abstract][Full Text] [Related]
12. Glutamate transporters and presynaptic metabotropic glutamate receptors protect neocortical Cajal-Retzius cells against over-excitation.
Dvorzhak A; Unichenko P; Kirischuk S
Pflugers Arch; 2012 Aug; 464(2):217-25. PubMed ID: 22665047
[TBL] [Abstract][Full Text] [Related]
13. Chemoenzymatic Synthesis and Pharmacological Characterization of Functionalized Aspartate Analogues As Novel Excitatory Amino Acid Transporter Inhibitors.
Fu H; Zhang J; Tepper PG; Bunch L; Jensen AA; Poelarends GJ
J Med Chem; 2018 Sep; 61(17):7741-7753. PubMed ID: 30011368
[TBL] [Abstract][Full Text] [Related]
14. Glutamate transporter blockers for elucidation of the function of excitatory neurotransmission systems.
Shimamoto K
Chem Rec; 2008; 8(3):182-99. PubMed ID: 18563834
[TBL] [Abstract][Full Text] [Related]
15. Differing effects of substrate and non-substrate transport inhibitors on glutamate uptake reversal.
Anderson CM; Bridges RJ; Chamberlin AR; Shimamoto K; Yasuda-Kamatani Y; Swanson RA
J Neurochem; 2001 Dec; 79(6):1207-16. PubMed ID: 11752061
[TBL] [Abstract][Full Text] [Related]
16. Rapid chemoenzymatic route to glutamate transporter inhibitor l-TFB-TBOA and related amino acids.
Fu H; Younes SH; Saifuddin M; Tepper PG; Zhang J; Keller E; Heeres A; Szymanski W; Poelarends GJ
Org Biomol Chem; 2017 Mar; 15(11):2341-2344. PubMed ID: 28244539
[TBL] [Abstract][Full Text] [Related]
17. Synaptic activation of presynaptic glutamate transporter currents in nerve terminals.
Palmer MJ; Taschenberger H; Hull C; Tremere L; von Gersdorff H
J Neurosci; 2003 Jun; 23(12):4831-41. PubMed ID: 12832505
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters.
Koch HP; Kavanaugh MP; Esslinger CS; Zerangue N; Humphrey JM; Amara SG; Chamberlin AR; Bridges RJ
Mol Pharmacol; 1999 Dec; 56(6):1095-104. PubMed ID: 10570036
[TBL] [Abstract][Full Text] [Related]
19. Syntheses of optically pure beta-hydroxyaspartate derivatives as glutamate transporter blockers.
Shimamoto K; Shigeri Y; Yasuda-Kamatani Y; Lebrun B; Yumoto N; Nakajima T
Bioorg Med Chem Lett; 2000 Nov; 10(21):2407-10. PubMed ID: 11078189
[TBL] [Abstract][Full Text] [Related]
20. Astrocyte glutamate transporters regulate metabotropic glutamate receptor-mediated excitation of hippocampal interneurons.
Huang YH; Sinha SR; Tanaka K; Rothstein JD; Bergles DE
J Neurosci; 2004 May; 24(19):4551-9. PubMed ID: 15140926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
